Comparison of endoscopic gastritis based on Kyoto classification between diffuse and intestinal gastric cancer.
Endoscopy
Gastric cancer
Gastritis
Kyoto classification
Lauren classification
Pathology
Journal
World journal of gastrointestinal endoscopy
ISSN: 1948-5190
Titre abrégé: World J Gastrointest Endosc
Pays: United States
ID NLM: 101532474
Informations de publication
Date de publication:
16 May 2021
16 May 2021
Historique:
received:
13
01
2021
revised:
14
02
2021
accepted:
14
04
2021
entrez:
28
5
2021
pubmed:
29
5
2021
medline:
29
5
2021
Statut:
ppublish
Résumé
Gastric cancers can be categorized into diffuse- and intestinal-type cancers based on the Lauren histopathological classification. These two subtypes show distinct differences in metastasis frequency, treatment application, and prognosis. Therefore, accurately assessing the Lauren classification before treatment is crucial. However, studies on the gastritis endoscopy-based Kyoto classification have recently shown that endoscopic diagnosis has improved. To investigate patient characteristics including endoscopic gastritis associated with diffuse- and intestinal-type gastric cancers in Patients who underwent esophagogastroduodenoscopy at the Toyoshima Endoscopy Clinic were enrolled. The Kyoto classification included atrophy, intestinal metaplasia, enlarged folds, nodularity, and diffuse redness. The effects of age, sex, and Kyoto classification score on gastric cancer according to the Lauren classification were analyzed. We developed the Lauren predictive background score based on the coefficients of a logistic regression model using variables independently associated with the Lauren classification. Area under the receiver operative characteristic curve and diagnostic accuracy of this score were examined. A total of 499 Patient backgrounds, such as age, sex, endoscopic intestinal metaplasia, and endoscopic enlarged folds are useful for predicting the Lauren type of gastric cancer.
Sections du résumé
BACKGROUND
BACKGROUND
Gastric cancers can be categorized into diffuse- and intestinal-type cancers based on the Lauren histopathological classification. These two subtypes show distinct differences in metastasis frequency, treatment application, and prognosis. Therefore, accurately assessing the Lauren classification before treatment is crucial. However, studies on the gastritis endoscopy-based Kyoto classification have recently shown that endoscopic diagnosis has improved.
AIM
OBJECTIVE
To investigate patient characteristics including endoscopic gastritis associated with diffuse- and intestinal-type gastric cancers in
METHODS
METHODS
Patients who underwent esophagogastroduodenoscopy at the Toyoshima Endoscopy Clinic were enrolled. The Kyoto classification included atrophy, intestinal metaplasia, enlarged folds, nodularity, and diffuse redness. The effects of age, sex, and Kyoto classification score on gastric cancer according to the Lauren classification were analyzed. We developed the Lauren predictive background score based on the coefficients of a logistic regression model using variables independently associated with the Lauren classification. Area under the receiver operative characteristic curve and diagnostic accuracy of this score were examined.
RESULTS
RESULTS
A total of 499
CONCLUSION
CONCLUSIONS
Patient backgrounds, such as age, sex, endoscopic intestinal metaplasia, and endoscopic enlarged folds are useful for predicting the Lauren type of gastric cancer.
Identifiants
pubmed: 34046150
doi: 10.4253/wjge.v13.i5.125
pmc: PMC8134854
doi:
Types de publication
Journal Article
Langues
eng
Pagination
125-136Informations de copyright
©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All other authors have nothing to disclose.
Références
Ann Oncol. 2019 Mar 1;30(3):431-438
pubmed: 30689702
Int J Cancer. 2012 Dec 1;131(11):2632-42
pubmed: 22383377
Br J Cancer. 2001 Feb 2;84(3):400-5
pubmed: 11161407
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Gastrointest Endosc. 2002 Aug;56(2):279-84
pubmed: 12145613
Endosc Int Open. 2015 Dec;3(6):E597-604
pubmed: 26716119
Gastrointest Endosc. 2018 Apr;87(4):1014-1022
pubmed: 29122604
N Engl J Med. 2001 Sep 13;345(11):784-9
pubmed: 11556297
World J Gastroenterol. 2014 Apr 14;20(14):3938-49
pubmed: 24744583
APMIS. 1994 Sep;102(9):711-5
pubmed: 7946275
Nat Genet. 2008 Jun;40(6):730-40
pubmed: 18488030
Scand J Gastroenterol. 1996 Jul;31(7):711-5
pubmed: 8819223
World J Gastroenterol. 2018 Sep 21;24(35):4061-4068
pubmed: 30254410
J Surg Oncol. 2019 Dec;120(7):1148-1153
pubmed: 31544969
Gastrointest Endosc. 2018 Feb;87(2):338-347
pubmed: 28966062
J Gastroenterol Hepatol. 2017 Sep;32(9):1581-1586
pubmed: 28217843
J Clin Biochem Nutr. 2021 Jan;68(1):101-104
pubmed: 33536719
Surg Endosc. 2013 Oct;27(10):3690-5
pubmed: 23588711
J Clin Invest. 2007 Jan;117(1):60-9
pubmed: 17200707
J Gastroenterol Hepatol. 2003 Dec;18(12):1384-91
pubmed: 14675267
Intern Med. 2017;56(6):579-586
pubmed: 28321054
Int J Cancer. 2012 Nov 15;131(10):2376-84
pubmed: 22362223
Gastrointest Endosc. 2014 Oct 16;80(6):1194-1198.e1
pubmed: 25442093
Endoscopy. 2019 Apr;51(4):365-388
pubmed: 30841008
Gastric Cancer. 2020 May;23(3):473-482
pubmed: 31773340
J Gastroenterol. 2020 Mar;55(3):281-288
pubmed: 31667586
Dig Endosc. 2020 Jan;32(1):74-83
pubmed: 31309632
Dig Endosc. 2013 Mar;25(2):136-46
pubmed: 23362997
Ann Transl Med. 2020 Mar;8(6):360
pubmed: 32355804
Int J Mol Sci. 2018 Dec 18;19(12):
pubmed: 30567376
Pathol Res Pract. 2013 May;209(5):314-8
pubmed: 23598070
Oncol Lett. 2016 May;11(5):2959-2964
pubmed: 27123046
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
World J Surg Oncol. 2019 Feb 13;17(1):32
pubmed: 30760272
World J Gastroenterol. 2014 May 21;20(19):5679-84
pubmed: 24914328
Aliment Pharmacol Ther. 2004 Aug 1;20(3):261-70
pubmed: 15274662
World J Gastroenterol. 2020 Sep 14;26(34):5146-5155
pubmed: 32982115
Gut. 2020 Dec;69(12):2113-2121
pubmed: 32205420
J Gastrointest Oncol. 2017 Feb;8(1):148-163
pubmed: 28280619
Br J Cancer. 2017 Sep 5;117(6):775-782
pubmed: 28765618